Skip to content
Treating HCV in PWID: Best Practices episode artwork

Apr 10, 2020 22 min

Treating HCV in PWID: Best Practices

from DKBmed Radio

Take our post-test to claim CME credits. To read a companion newsletter click here. Hepatitis C has become “curable” for >90% of those infected. But while universal HCV elimination is medically possible, this goal is compromised by certain populations who remain underscreened, undertreated, and underserved and continue to spread the virus. One such population is people who inject drugs (PWID). In this issue, Dr. Brianna Norton and Dr. Matthew Akiyama from the Albert Einstein College of Medicine analyze the most important data to explain how substance use impacts adherence and the risk of HCV reinfection.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Treating HCV in PWID: Best Practices

0:00 22:34

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of DKBmed Radio?

This episode is 22 minutes long.

When was this DKBmed Radio episode published?

This episode was published on April 10, 2020.

Can I download this DKBmed Radio episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.